Incyte INCY
NASDAQ INCY
$127.67 -0.33 (-0.26%)
As of: Sep 4, 2026 · 3:14 PM EDT

Incyte (INCY) Inventory Average (2012 - 2026)

Incyte's (INCY) quarterly Inventory Average came in at $114.1 million in Q2 2026, up 54.77% YoY from $73.7 million in Q2 2025, and up 5.3% on a QoQ basis from $108.3 million in Q1 2026.

Analysis

Incyte (INCY) Inventory Average (2012 - 2026) Analysis & Trends

Incyte (INCY) has 15 years of Inventory Average data on file, last reported at $114.1 million in Q2 2026.

  • Quarterly Inventory Average rose 54.77% year-over-year to $114.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $114.1 million (up 54.77% YoY) and the FY2025 annual result came in at $80.0 million, up 31.26% from the prior year.
  • Inventory Average climbed to $114.1 million in Q2 2026, from $108.3 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $114.1 million in Q2 2026 to a low of $31.7 million in Q1 2022.
  • A 5-year average of $65.9 million and a median of $62.4 million in 2024 frame the typical range for Inventory Average.
  • Annual changes were most pronounced in 2022 — Inventory Average surged 169.47% — and 2023, when it declined 14.63%.
  • Tracing INCY's Inventory Average over 5 years: stood at $43.9 million in 2022, then soared by 36.72% to $60.1 million in 2023, then gained by 7.61% to $64.7 million in 2024, then soared by 42.68% to $92.3 million in 2025, then advanced by 23.66% to $114.1 million in 2026.
  • The last three Inventory Average figures came in at $114.1 million (Q2 2026), $108.3 million (Q1 2026), and $92.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 1.77 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 3.09 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 213.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 707.10 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 90.57 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 137.65 Mn
10 Incyte 25.59 Bn 21.05 Bn 1.57 Bn 114.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 114.08 Mn
Mar 31, 2026 108.34 Mn
Dec 31, 2025 92.25 Mn
Sep 30, 2025 83.44 Mn
Jun 30, 2025 73.71 Mn
Mar 31, 2025 61.44 Mn
Dec 31, 2024 64.66 Mn
Sep 30, 2024 85.57 Mn
Jun 30, 2024 82.17 Mn
Mar 31, 2024 63.31 Mn
Dec 31, 2023 60.09 Mn
Sep 30, 2023 46.57 Mn
Jun 30, 2023 38.42 Mn
Mar 31, 2023 41.45 Mn
Dec 31, 2022 43.95 Mn
Sep 30, 2022 50.20 Mn
Jun 30, 2022 45.00 Mn
Mar 31, 2022 31.70 Mn
Dec 31, 2021 24.60 Mn
Sep 30, 2021 19.00 Mn